Vanguard Portfolio Management
STIM icon

Vanguard Portfolio Management’s Neuronetics STIM Stock Holding History

Vanguard Portfolio Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-221,170
Closed -$321K – 3243
2026
Q1 		$321K Buy
+221,170
New +$351K ﹤0.01% 3004

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management's STIM Position: Q2 2026 in Review

Vanguard Portfolio Management sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 221,170 shares — an estimated $321K sold.

Vanguard Portfolio Management first reported a position in STIM in Q1 2026 and held it in 1 quarter. The position peaked at $321K in Q1 2026. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Vanguard Portfolio Management reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Vanguard Portfolio Management sold 221,170 Neuronetics shares in Q2 2026, an estimated $321K.
  • Vanguard Portfolio Management first reported a position in Neuronetics in Q1 2026 and held it in 1 quarter.
  • Vanguard Portfolio Management's Neuronetics position peaked at $321K in Q1 2026.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.